Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Nicotine Dependence and Acute Depression
NCT00186446Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jun 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in major depressive disorder (MDD), nicotine dependence, sponsored by Stanford University. Started Jun 2004; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)nicotine dependence
Beyond the preview
Go deeper on NCT00186446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186446.